Low-dose oncolytic adenovirus therapy overcomes tumor-induced immune suppression and sensitizes intracranial gliomas to anti-PD-1 therapy

  • Zineb Belcaid
  • , Cor Berrevoets
  • , John Choi
  • , Edward Van Beelen
  • , Eftychia Stavrakaki
  • , Tessa Pierson
  • , Jenneke Kloezeman
  • , Denis Routkevitch
  • , Mariëlle Van Der Kaaij
  • , Alicia Van Der Ploeg
  • , Dimitrios Mathios
  • , Stefan Sleijfer
  • , Clemens Dirven
  • , Michael Lim
  • , Reno Debets
  • , Martine L.M. Lamfers

Research output: Contribution to journal › Article › peer-review

43 Scopus citations

Fingerprint

Dive into the research topics of 'Low-dose oncolytic adenovirus therapy overcomes tumor-induced immune suppression and sensitizes intracranial gliomas to anti-PD-1 therapy'. Together they form a unique fingerprint.

Medicine and Dentistry

Keyphrases

Immunology and Microbiology